Kaduszkiewicz, Hanna
Christian-Albrechts-Universität zu Kiel
8 papers on CoChatORCID 0000-0003-2035-6015
Most cited papers
- Verified
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials
Kaduszkiewicz, H., Zimmermann, T., Beck-Bornholdt, H.-P., & van den Bussche, H. (2005) · BMJ
Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research
Cited by 522
- Verified
AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
Jessen, F., Wolfsgruber, S., Wiese, B., Bickel, H., Mösch, E., Kaduszkiewicz, H., Pentzek, M., Riedel‐Heller, S. G., Luck, T., Fuchs, A., et al. (2014) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies
Cited by 511
- Verified
Anticholinergic drug use and risk for dementia: target for dementia prevention
Jessen, F., Kaduszkiewicz, H., Daerr, M., Bickel, H., Pentzek, M., Riedel-Heller, S., Wagner, M., Weyerer, S., Wiese, B., van den Bussche, H., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience
Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes
Cited by 119
- Verified
A multidomain intervention against cognitive decline in an at-risk-population in Germany: results from the cluster-randomized AgeWell.de trial
Zülke, A. E., Pabst, A., Luppa, M., Roehr, S., Seidling, H., Oey, A., Cardona, M. I., Blotenberg, I., Bauer, A., Weise, S., et al. (2024) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchNutrition and Health in Aging
Cited by 90
- Verified
Treatment preferences for depression in the elderly
Luck-Sikorski, C., Stein, J., Heilmann, K., Maier, W., Kaduszkiewicz, H., Scherer, M., Weyerer, S., Werle, J., Wiese, B., Moor, L., et al. (2017) · International Psychogeriatrics
Mental Health Treatment and AccessPsychotherapy Techniques and Applications
Cited by 42
- Verified
Potentially inappropriate medication: Association between the use of antidepressant drugs and the subsequent risk for dementia.
Heser, K., Luck, T., Röhr, S., Wiese, B., Kaduszkiewicz, H., Oey, A., Bickel, H., Mösch, E., Weyerer, S., Werle, J., et al. (2018) · Journal of Affective Disorders
Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research
Cited by 38
- Verified
Prediction of dementia of Alzheimer type by different types of subjective cognitive decline
Jessen, F., Kleineidam, L., Wolfsgruber, S., Bickel, H., Brettschneider, C., Fuchs, A., Kaduszkiewicz, H., König, H., Mallon, T., Mamone, S., et al. (2020) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies
Cited by 37
- Verified
The impact of depressive symptoms on healthcare costs in late life: longitudinal findings from the agemoode study
Bock, J.-O., Hajek, A., Weyerer, S., Werle, J., Wagner, M., Maier, W., Stark, A., Kaduszkiewicz, H., Wiese, B., Moor, L., et al. (2017) · The American Journal of Geriatric Psychiatry
Mental Health Treatment and AccessHealth Systems, Economic Evaluations, Quality of Life
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free